Ertapenem versus piperacillin/tazobactam for diabetic foot infections in China: a Phase 3, multicentre, randomized, double-blind, active-controlled, non-inferiority trial

Zhangrong Xu, Jue Wang, Ju-fang Shen et al.|Journal of Antimicrobial Chemotherapy|2016

Cited by 27